Leash Bio
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Leash Bio - overview
Established
2021
Location
Salt Lake City, UT, US
Primary Industry
Biotechnology
About
Founded in 2021 and based in Utah, US, Leash Bio operates as a biotechnology research firm that is building datasets of medicinal chemistry compounds using machine learning. Ian Quigley (CEO) and Andrew Blevins (CTO) are the co-founders of the company. In April 2024, Leash Bio raised USD 9. 3 million in seed funding led by SpringTide Capital Management, including Metaplanet Holdings, Top Harvest Capital, Mitsui & Co.
Global Investment, and MFV Partners. The company offers a proprietary platform that is built upon a dataset compiled through screening of compounds against proteins, resulting in data points. This dataset serves as the foundation for training machine learning models, enabling them to identify drug candidates with accuracy. The firm’s platform also encompasses a cyclical engine that continuously iterates through data collection, machine learning, and refinement processes.
Leash Bio’s software further enhances its capabilities, facilitating the design and optimization of chemical matter. The organization plans to use the April 2024 funding to support the development of its foundational machine-learning model.
Current Investors
Mitsui Global Investment, MFV Partners, Metaplanet Holdings
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biotechnology
Website
www.leash.bio/
Verticals
Artificial Intelligence
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Leash Bio - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.